Tick-borne encephalitis vaccine recommended for US travelers

According to the 2023 Advisory Committee on Immunization Practices (ACIP), the tick-borne encephalitis (TBE) vaccine is recommended for individuals in the United States who travel to an area where the disease is endemic and are likely to have extensive exposure to infected ticks during outdoor activities. The vaccine is also recommended for laboratory workers who may be exposed to the virus. These recommendations were published in Morbidity and Mortality Weekly Report. Members of the ACIP convened from September 2020 to March 2022 to prepare evidence-based TBE vaccine recommendations based on the epidemiology and outcomes of TBE, disease risk/burden, TBE vaccine safety, immunogenicity, and effectiveness. They used the Grading of Recommendations Assessment, Development, and Evaluation approach to analyze available data. The Food and Drug Administration approved the TBE vaccine in August 2021 for US individuals aged 1 year and older. Of note, a measure of protection against clinical disease conferred by TBE vaccination alone...